Bizzarri M - Search Results

1

An innovative approach to polycystic ovary syndrome.

Bizzarri M, Logoteta P, Monastra G, Laganà AS. Bizzarri M, et al. J Obstet Gynaecol. 2022 May;42(4):546-556. doi: 10.1080/01443615.2021.1920006. Epub 2021 Jun 25. J Obstet Gynaecol. 2022. PMID: 34169781 Review.

2

Solid phase extraction and high performance liquid chromatographic determination of doxophylline in plasma.

Lagana A, Bizzarri M, Marino A, Mancini M. Lagana A, et al. Among authors: bizzarri m. Biomed Chromatogr. 1990 Sep;4(5):205-7. doi: 10.1002/bmc.1130040507. Biomed Chromatogr. 1990. PMID: 2279147

3

Determination of urinary tryptophan and its metabolites along the nicotinic acid pathway by high performance liquid chromatography with ultraviolet detection.

Bizzarri M, Catizone A, Pompei M, Chiappini L, Curini L, Lagana A. Bizzarri M, et al. Biomed Chromatogr. 1990 Jan;4(1):24-7. doi: 10.1002/bmc.1130040104. Biomed Chromatogr. 1990. PMID: 2310838

4

Correlation of serum sialic acid fractions as markers for carcinoma of the uterine cervix.

Lagana A, Martinez BP, Marino A, Fago G, Bizzarri M. Lagana A, et al. Among authors: bizzarri m. Anticancer Res. 1995 Sep-Oct;15(5B):2341-6. Anticancer Res. 1995. PMID: 8572649

5

Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker.

Laganà A, Pardo-Martínez B, Marino A, Fago G, Bizzarri M. Laganà A, et al. Among authors: bizzarri m. Clin Chim Acta. 1995 Dec 29;243(2):165-79. doi: 10.1016/0009-8981(95)06165-7. Clin Chim Acta. 1995. PMID: 8747492 Clinical Trial.

6

Inositol: history of an effective therapy for Polycystic Ovary Syndrome.

Bizzarri M, Carlomagno G. Bizzarri M, et al. Eur Rev Med Pharmacol Sci. 2014 Jul;18(13):1896-903. Eur Rev Med Pharmacol Sci. 2014. PMID: 25010620 Free article.

7

The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.

Dinicola S, Chiu TT, Unfer V, Carlomagno G, Bizzarri M. Dinicola S, et al. Among authors: bizzarri m. J Clin Pharmacol. 2014 Oct;54(10):1079-92. doi: 10.1002/jcph.362. Epub 2014 Jul 18. J Clin Pharmacol. 2014. PMID: 25042908 Review.

8

Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS.

Facchinetti F, Bizzarri M, Benvenga S, D'Anna R, Lanzone A, Soulage C, Di Renzo GC, Hod M, Cavalli P, Chiu TT, Kamenov ZA, Bevilacqua A, Carlomagno G, Gerli S, Oliva MM, Devroey P. Facchinetti F, et al. Among authors: bizzarri m. Eur J Obstet Gynecol Reprod Biol. 2015 Dec;195:72-76. doi: 10.1016/j.ejogrb.2015.09.024. Epub 2015 Oct 3. Eur J Obstet Gynecol Reprod Biol. 2015. PMID: 26479434

9

Physiological role and clinical utility of inositols in polycystic ovary syndrome.

Bevilacqua A, Bizzarri M. Bevilacqua A, et al. Among authors: bizzarri m. Best Pract Res Clin Obstet Gynaecol. 2016 Nov;37:129-139. doi: 10.1016/j.bpobgyn.2016.03.007. Epub 2016 Apr 1. Best Pract Res Clin Obstet Gynaecol. 2016. PMID: 27117028 Review.

10

Does myo-inositol effect on PCOS follicles involve cytoskeleton regulation?

Bizzarri M, Cucina A, Dinicola S, Harrath AH, Alwasel SH, Unfer V, Bevilacqua A. Bizzarri M, et al. Med Hypotheses. 2016 Jun;91:1-5. doi: 10.1016/j.mehy.2016.03.014. Epub 2016 Apr 4. Med Hypotheses. 2016. PMID: 27142131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page